QIAGEN OmicSoft and Biomedical Knowledge Base

Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and public single-cell data

October 12, 2023
Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to:

• View host immune response clusters across TCGA samples
• Identify differentially expressed immunomodulators across sample groups
• Visualize single-cell dimension reduction maps and overlay expression data
• Identify potential biomarkers whose expression correlates or anti-correlates with targets genes
• Validate new biomarkers using custom queries and TCGA survival data

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Supporting Biomarker Discovery One Cell at a Time - Introduction to QIAGEN OmicSoft Single Cell...

239 views April 05, 2021

Single-cell gene expression analysis helps biologists and bioinformaticians...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

70 views September 06, 2023

In this 90-minute training, you'll learn how to perform drug treatment,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

108 views August 16, 2023

Research and development for new drugs and disease treatments can be lengthy...

QIAGEN OmicSoft and Biomedical Knowledge Base

Target exploration and cell line selection for drug discovery

130 views July 21, 2023

Cancer cell line models have been a cornerstone of cancer research for...